Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Lipsitch

Showing results (61-70 of 446) with videos related to

Pageof 45
Sort By:
Mbio|October 11, 2012
Rethinking biosafety in research on potential pandemic pathogensMarc Lipsitch, Barry R Bloom
American Journal of Epidemiology|September 9, 2004
Invited commentary: real-time tracking of control measures for emerging infectionsMarc Lipsitch, Carl T Bergstrom
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 17, 2011
Oseltamivir and risk of lower respiratory tract complications in patients with flu symptoms: a meta-analysis of eleven randomized clinical trialsMiguel A Hernán, Marc Lipsitch
Mbio|December 16, 2014
Moratorium on research intended to create novel potential pandemic pathogensMarc Lipsitch, Thomas V Inglesby
The Lancet. Respiratory Medicine|August 5, 2018
Can antibiotic resistance be reduced by vaccinating against respiratory disease?Katherine E Atkins, Marc Lipsitch
Science (New York, N.Y.)|September 10, 2016
Zika vaccine trialsMarc Lipsitch, Benjamin J Cowling
American Journal of Epidemiology|July 11, 2020
Statistical Properties of Stepped Wedge Cluster-Randomized Trials in Infectious Disease OutbreaksLee Kennedy-Shaffer, Marc Lipsitch
Proceedings of the National Academy of Sciences of the United States of America|December 19, 2018
Microbiome as a tool and a target in the effort to address antimicrobial resistanceDavid A Relman, Marc Lipsitch
Emerging Infectious Diseases|April 25, 2002
Antimicrobial use and antimicrobial resistance: a population perspectiveMarc Lipsitch, Matthew H Samore
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 26, 2013
Oseltamivir effect on antibiotic-treated lower respiratory tract complications in virologically positive randomized trial participantsMarc Lipsitch, Miguel A Hernán
Pageof 45

Showing results (61-70 of 446) with videos related to

Sort By:
Pageof 45
Mbio|October 11, 2012
Rethinking biosafety in research on potential pandemic pathogensMarc Lipsitch, Barry R Bloom
American Journal of Epidemiology|September 9, 2004
Invited commentary: real-time tracking of control measures for emerging infectionsMarc Lipsitch, Carl T Bergstrom
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 17, 2011
Oseltamivir and risk of lower respiratory tract complications in patients with flu symptoms: a meta-analysis of eleven randomized clinical trialsMiguel A Hernán, Marc Lipsitch
Mbio|December 16, 2014
Moratorium on research intended to create novel potential pandemic pathogensMarc Lipsitch, Thomas V Inglesby
The Lancet. Respiratory Medicine|August 5, 2018
Can antibiotic resistance be reduced by vaccinating against respiratory disease?Katherine E Atkins, Marc Lipsitch
Science (New York, N.Y.)|September 10, 2016
Zika vaccine trialsMarc Lipsitch, Benjamin J Cowling
American Journal of Epidemiology|July 11, 2020
Statistical Properties of Stepped Wedge Cluster-Randomized Trials in Infectious Disease OutbreaksLee Kennedy-Shaffer, Marc Lipsitch
Proceedings of the National Academy of Sciences of the United States of America|December 19, 2018
Microbiome as a tool and a target in the effort to address antimicrobial resistanceDavid A Relman, Marc Lipsitch
Emerging Infectious Diseases|April 25, 2002
Antimicrobial use and antimicrobial resistance: a population perspectiveMarc Lipsitch, Matthew H Samore
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 26, 2013
Oseltamivir effect on antibiotic-treated lower respiratory tract complications in virologically positive randomized trial participantsMarc Lipsitch, Miguel A Hernán
Pageof 45